The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 30, 2006

Filed:

May. 13, 1999
Applicants:

Walter Elger, Berlin, DE;

Pekka Lähteenmäki, Turku, FI;

Matti Lehtinen, Piispanristi, FI;

Gudrun Reddersen, Jena, DE;

Holger Zimmermann, Ilmenau-Roda, DE;

Michael Oettel, Jena, DE;

Sigfrid Schwarz, Jena, DE;

Inventors:

Walter Elger, Berlin, DE;

Pekka Lähteenmäki, Turku, FI;

Matti Lehtinen, Piispanristi, FI;

Gudrun Reddersen, Jena, DE;

Holger Zimmermann, Ilmenau-Roda, DE;

Michael Oettel, Jena, DE;

Sigfrid Schwarz, Jena, DE;

Assignee:

Schering AG, Berlin, DE;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/56 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to the use of biogenic estrogen sulfamates for the oral discontinuous application for hormone replacement therapy (HRT). The discontinuous administration takes place in intervals ranging from 2 to 40 days. The invention also provides the additional application of gestagens, preferably continuously in the form of an implant or in the form of an intrauterine releasing system (IUD). Estrone sulfamate, estradiol sulfamate or an N-acyl sulfamate of estrone, estradiol or estriol having up to 7 C-atoms in the acyl chain, or a combination comprised of two or more of said active ingredients are used as biogenic estrogen sulfamates.


Find Patent Forward Citations

Loading…